1. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China. 2. Department of Radiation and Medical Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming, China. 3. Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. 4. Department of Pathology, China Three Gorges University Medical College, Yichang, China. 5. Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China. 6. Central Laboratory of Xinhua Hospital of Dalian University, Department of Medical Oncology, Xinhua Hospital of Dalian University, Dalian, China. 7. Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. 8. Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China. #These authors contributed equally to this work.
✉ Corresponding authors: Conghua Xie, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China, Phone: +86-27-67812607, Email: chxie_65edu.cn; and Yan Gong, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China, Phone: +86-27-67811461, Email: yan.gongedu.cn.More
Citation:
Sun Y, Sun X, You C, Ma S, Luo Y, Peng S, Tang F, Tian X, Wang F, Huang Z, Yu H, Xiao Y, Wang X, Zhang J, Gong Y, Xie C. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. Int J Biol Sci 2022; 18(16):6226. doi:10.7150/ijbs.79140. https://www.ijbs.com/v18p6226.htm
Sun, Y., Sun, X., You, C., Ma, S., Luo, Y., Peng, S., Tang, F., Tian, X., Wang, F., Huang, Z., Yu, H., Xiao, Y., Wang, X., Zhang, J., Gong, Y., Xie, C. (2022). MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. International Journal of Biological Sciences, 18(16), 6226. https://doi.org/10.7150/ijbs.79140.
ACS
Sun, Y.; Sun, X.; You, C.; Ma, S.; Luo, Y.; Peng, S.; Tang, F.; Tian, X.; Wang, F.; Huang, Z.; Yu, H.; Xiao, Y.; Wang, X.; Zhang, J.; Gong, Y.; Xie, C. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. Int. J. Biol. Sci. 2022, 18 (16), 6226. DOI: 10.7150/ijbs.79140.
NLM
Sun Y, Sun X, You C, Ma S, Luo Y, Peng S, Tang F, Tian X, Wang F, Huang Z, Yu H, Xiao Y, Wang X, Zhang J, Gong Y, Xie C. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. Int J Biol Sci 2022; 18(16):6226. doi:10.7150/ijbs.79140. https://www.ijbs.com/v18p6226.htm
CSE
Sun Y, Sun X, You C, Ma S, Luo Y, Peng S, Tang F, Tian X, Wang F, Huang Z, Yu H, Xiao Y, Wang X, Zhang J, Gong Y, Xie C. 2022. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. Int J Biol Sci. 18(16):6226.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.